Kalogon raises $5.75M Series A to make sitting healthier for all
What's the deal? KalogonDealroom has a profile for this one. Try Dealroom →, a smart seating company founded by former SpaceX engineers, has raised $5.75M to expand its technology that reduces the health risks of prolonged sitting. Enable VenturesDealroom has a profile for this one. Try Dealroom → — the first venture fund focused on closing the disability wealth gap — led the round, with participation from Florida Opportunity FundDealroom has a profile for this one. Try Dealroom →, Castellan GroupDealroom has a profile for this one. Try Dealroom →, and returning investors DeepWork CapitalDealroom has a profile for this one. Try Dealroom →, Sawmill AngelsDealroom has a profile for this one. Try Dealroom →, and Black OpalDealroom has a profile for this one. Try Dealroom →.
The Melbourne, Florida-based company will use the capital to hire across engineering, research, and business development, expand its product line internationally, and invest in data intelligence from its growing fleet of deployed smart cushions.
Why now? Kalogon more than tripled its medical revenue year-over-year and recently moved into a dedicated manufacturing facility to meet rising demand. Its flagship product, Orbiter, is a smart wheelchair cushion clinically validated to improve blood flow and comfort — addressing pressure injuries that claim more lives annually than nearly any form of cancer and cost the US healthcare system an estimated $20B a year.
The same technology is now in pilot testing with the US Air Force, helping aircrew on B-52 and E-4B long-duration missions manage fatigue and pain. Commercial aviation and automotive partnerships are also in development.
"When you solve for the people with the greatest need, you end up solving it for everyone," said Tim Balz, founder and chief executive officer of Kalogon. "Our work with the US Air Force showed us that the same technologies that help wheelchair users can help a B-52 pilot endure a 30-hour mission at peak performance."
What could go wrong? Kalogon is betting it can stretch a disability-focused product into aviation, automotive, and other mass markets — a leap that demands very different sales channels, certifications, and customer expectations. Scaling hardware manufacturing across multiple verticals with $5.75M is ambitious, and larger incumbents in automotive and aviation seating could move to compete.
The signal: Kalogon, still at the early growth stage according to Dealroom, is an unusual bet for a disability-focused fund leading a round alongside a mix of regional and angel investors — suggesting the thesis here is less about scale today and more about compounding data from every deployed cushion. With military pilots and wheelchair users generating real-world seating intelligence across very different use cases, the company's moat may ultimately be its dataset rather than its hardware.
Read more: Statesman-Examiner
